• This record comes from PubMed

ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change

. 2020 Apr ; 476 (4) : 615-619. [epub] 20200114

Language English Country Germany Media print-electronic

Document type Case Reports, Journal Article

Links

PubMed 31938824
DOI 10.1007/s00428-020-02744-5
PII: 10.1007/s00428-020-02744-5
Knihovny.cz E-resources

We report on 51-year-old woman who presented with brown discharge and postcoital bleeding due to myoma nascens-like polypoid mass distending cervical canal. Histologically, the tumor consisted of high-grade spindle cell component with up to 15 mitotic figures per 10 HPF and also low-grade leiomyoma-like areas with focal myxoid change and so far undescribed cytoplasmic signet ring cell change. Immunohistochemically Desmin, actin, and h-caldesmon were negative. Conversely, BCOR positive expression was coupled with Cyclin D1 positivity and was antibody clone dependent. The molecular NGS and FISH study identified reciprocal fusion gene ZC3H7B-BCOR. In conclusion, these findings further support the idea of routine reflex molecular testing of uterine mesenchymal tumors with unusual clinical presentation or in case malignancy is suspected. Lastly, we suggest ZC3H7B-BCOR rearranged high-grade endometrial stromal sarcoma might be considered as a tumor suitable for BCL6-targeted treatment.

Comment In

PubMed

See more in PubMed

Virchows Arch. 2018 Nov;473(5):583-590 PubMed

Genes Chromosomes Cancer. 2013 Jul;52(7):610-8 PubMed

Am J Surg Pathol. 2017 Jan;41(1):12-24 PubMed

Mod Pathol. 2018 Apr;31(4):674-684 PubMed

Virchows Arch. 2018 Dec;473(6):665-678 PubMed

Genes Dev. 2000 Jul 15;14(14):1810-23 PubMed

Am J Surg Pathol. 2019 May;43(5):662-669 PubMed

Pathology. 2018 Feb;50(2):162-177 PubMed

Int J Gynecol Pathol. 2019 Sep;38(5):420-425 PubMed

Expert Opin Ther Targets. 2018 Feb;22(2):143-152 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...